Shree Ganesh Biotech India Ltd Q1FY23 net profit at Rs. 1.03 crore

has reported Standalone financial results for the period ended June 30, 2022.

Financial Results (Q1 FY2023) - QoQ Comparison

The company has reported total income of Rs. 20.4745 crores during the period ended June 30, 2022 as compared to Rs. 20.1392 crores during the period ended March 31, 2022.

The company has posted net profit / (loss) of Rs. 1.0317 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs. 1.0431 crores for the period ended March 31, 2022.

The company has reported EPS of Rs. 0.0258 for the period ended June 30, 2022 as compared to Rs. 0.0523 for the period ended March 31, 2022.

Financials	Q1 FY2023	Q4 FY2022	% Change
Total Income	₹20.4745 crs	₹20.1392 crs	1.66%
Net Profit	₹1.0317 crs	₹1.0431 crs	-1.09%
EPS	₹ 0.0258	₹0.0523	-50.67%

Financial Results (Q1 FY2023) - YoY Comparison

The company has reported total income of Rs.20.4745 crores during the period ended June 30, 2022 as compared to Rs.15.5625 crores during the period ended June 30, 2021.

The company has posted net profit / (loss) of Rs.1.0317 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs.0.6822 crores for the period ended June 30, 2021.

The company has reported EPS of Rs. 0.0258 for the period ended June 30, 2022 as compared to Rs.0.0342 for the period ended June 30, 2021.

Financials	Q1 FY2023	Q1 FY2022	% Change
Total Income	₹20.4745 crs	₹15.5625 crs	31.56%
Net Profit	₹1.0317 crs	₹0.6822 crs	51.23%
EPS	₹ 0.0258	₹0.0342	-24.56%

Source : Equity Bulls

Keywords

ShreeGaneshBiotechIndia Q1FY23 ResultUpdate